共有 50 笔近期内部人交易记录记录，涉及 Sutro Biopharma, Inc. (STRO), 包括 32 笔买入 和 15 笔卖出. 内部人买入总额为 $796.23K 内部人卖出总额为 $76.16K.
近期活跃的重要内部人包括 Chung Jane, Pauling David, Chow Gregory K.. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — STRO
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-04 |
Chung Jane |
Chief Executive Officer |
期权行权（卖出） |
788 |
- |
- |
- |
| 2026-03-04 |
Pauling David |
Chief Admin. Ofcr. & Gc |
期权行权（卖出） |
675 |
- |
- |
- |
| 2026-03-02 |
Chow Gregory K. |
CFO |
限制性股票授予 (RSU) |
5,000 |
- |
- |
5,000 |
| 2026-03-02 |
Chung Jane |
Chief Executive Officer |
RSU 预扣税 |
2,779 |
$20.55 |
$57.11K |
20,779 |
| 2026-03-02 |
Gerber Hans-peter |
Chief Scientific Officer |
限制性股票授予 (RSU) |
5,000 |
- |
- |
5,000 |
| 2026-03-02 |
Pauling David |
Chief Admin. Ofcr. & Gc |
限制性股票授予 (RSU) |
4,200 |
- |
- |
4,200 |
| 2026-03-01 |
Chung Jane |
Chief Executive Officer |
期权行权（卖出） |
688 |
- |
- |
688 |
| 2026-03-01 |
Gerber Hans-peter |
Chief Scientific Officer |
期权行权（卖出） |
1,125 |
- |
- |
2,250 |
| 2026-03-01 |
Pauling David |
Chief Admin. Ofcr. & Gc |
期权行权（卖出） |
500 |
- |
- |
500 |
| 2025-12-23 |
Panek James P |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Matsui Connie |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Petree Daniel H |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Lobacki Joseph M |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Jagpal Sukhi |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Wigginton Jon Marc |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Dybbs Michael |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Chow Gregory K. |
CFO |
限制性股票授予 (RSU) |
8,200 |
$10.38 |
$85.12K |
8,200 |
| 2025-12-23 |
Hunter Heidi |
Director |
限制性股票授予 (RSU) |
1,500 |
$10.38 |
$15.57K |
1,500 |
| 2025-12-23 |
Gerber Hans-peter |
Chief Scientific Officer |
限制性股票授予 (RSU) |
7,925 |
$10.38 |
$82.26K |
7,925 |
| 2025-12-23 |
Pauling David |
Chief Admin. Ofcr. & Gc |
限制性股票授予 (RSU) |
7,200 |
$10.38 |
$74.74K |
7,200 |
| 2025-12-12 |
Chung Jane |
Chief Executive Officer |
期权行权（卖出） |
2,500 |
- |
- |
5,000 |
| 2025-10-15 |
Matsui Connie |
Director |
知情买入 |
50,000 |
$0.80 |
$39.95K |
50,000 |
| 2025-10-15 |
Chow Gregory K. |
CFO |
知情买入 |
19,750 |
$0.81 |
$16K |
19,750 |
| 2025-10-15 |
Chung Jane |
Chief Executive Officer |
知情买入 |
12,500 |
$0.80 |
$10.01K |
122,850 |
| 2025-10-15 |
Gerber Hans-peter |
Chief Scientific Officer |
知情买入 |
17,000 |
$0.80 |
$13.61K |
71,832 |
| 2025-10-15 |
Pauling David |
Chief Admin. Ofcr. & Gc |
知情买入 |
12,504 |
$0.80 |
$9.99K |
71,737 |
| 2025-09-18 |
Gerber Hans-peter |
Chief Scientific Officer |
RSU 预扣税 |
13,417 |
$0.90 |
$12.08K |
54,832 |
| 2025-08-09 |
Chung Jane |
Chief Executive Officer |
期权行权（卖出） |
18,750 |
- |
- |
- |
| 2025-07-08 |
Leyman Barbara |
Chief Business Officer |
RSU 预扣税 |
8,944 |
$0.78 |
$6.98K |
16,056 |
| 2025-06-06 |
Panek James P |
Director |
限制性股票授予 (RSU) |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Matsui Connie |
Director |
限制性股票授予 (RSU) |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Petree Daniel H |
Director |
限制性股票授予 (RSU) |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Lobacki Joseph M |
Director |
限制性股票授予 (RSU) |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Jagpal Sukhi |
Director |
限制性股票授予 (RSU) |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Wigginton Jon Marc |
Director |
限制性股票授予 (RSU) |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Dybbs Michael |
Director |
限制性股票授予 (RSU) |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-06 |
Hunter Heidi |
Director |
限制性股票授予 (RSU) |
50,000 |
$0.85 |
$42.5K |
50,000 |
| 2025-06-02 |
Chow Gregory K. |
Officer |
未知 |
- |
- |
- |
- |
| 2025-06-02 |
Chow Gregory K. |
CFO |
限制性股票授予 (RSU) |
100,000 |
- |
- |
100,000 |
| 2025-05-15 |
Albini Edward C |
CFO and Secretary |
期权行权（卖出） |
9,125 |
- |
- |
- |
| 2025-05-01 |
Fitzpatrick Linda A |
Chief People & Comm. Officer |
期权行权（卖出） |
9,125 |
- |
- |
- |
| 2025-05-01 |
Borgman Anne Elizabeth |
Chief Medical Officer |
期权行权（卖出） |
15,938 |
- |
- |
17,812 |
| 2025-05-01 |
Srinivasan Venkatesh |
Chief Tech Op Officer |
期权行权（卖出） |
2,500 |
- |
- |
5,000 |
| 2025-04-11 |
Srinivasan Venkatesh |
Chief Tech Op Officer |
期权行权（卖出） |
21,250 |
- |
- |
21,250 |
| 2025-04-04 |
Pauling David |
Chief Admin. Ofcr. & Gc |
未知 |
- |
- |
- |
56,733 |
| 2025-04-04 |
Chung Jane |
Chief Executive Officer |
限制性股票授予 (RSU) |
310,000 |
- |
- |
310,000 |
| 2025-04-04 |
Srinivasan Venkatesh |
Chief Tech Op Officer |
限制性股票授予 (RSU) |
94,250 |
- |
- |
94,250 |
| 2025-04-04 |
Gerber Hans-peter |
Chief Scientific Officer |
限制性股票授予 (RSU) |
113,750 |
- |
- |
113,750 |
| 2025-04-04 |
Leyman Barbara |
Chief Business Dev. Officer |
限制性股票授予 (RSU) |
84,500 |
- |
- |
84,500 |
| 2025-04-04 |
Pauling David |
Chief Admin. Ofcr. & Gc |
未知 |
25,275 |
- |
- |
- |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
